Garry E Menzel Tcr2 Therapeutics Inc. (TCRR) insider trading activity

TCRR Quotes by TradingView

Garry E Menzel Transaction History

Date Transaction Value Shares Traded Form
Jun 01 2023
SELL
Sale (or disposition) back to the issuer
-
265,459
Jul 05 2022
SELL
Bona fide gift
-
84,527
Jul 05 2022
BUY
Bona fide gift
-
265,459

Also insider at

STOK
Stoke Therapeutics, Inc. Healthcare
BDTX
Black Diamond Therapeutics, Inc. Healthcare
ADAP
Adaptimmune Therapeutics PLC Healthcare
Director
GEM

Garry E Menzel

President and CEO
Cambridge, MA

Track Institutional and Insider Activities on TCRR

Follow TCR2 THERAPEUTICS INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCRR shares.

Notify only if

Insider Trading

Get notified when an Tcr2 Therapeutics Inc. insider buys or sells TCRR shares.

Notify only if

News

Receive news related to TCR2 THERAPEUTICS INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TCRR